VNDA - Vanda Pharmaceuticals Inc.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Vanda Pharmaceuticals Q4 Earnings Preview
• Vanda updates on FDA review for Hetlioz label expansion
• Fed court allows Vanda lawsuit against FDA to move forward
• Biggest stock movers today: Google, AMD, GameStop, C3.AI, Chewy and more
• Vanda stock jumps on $100M license deal for MS drug from J&J unit
• Vanda Pharma stock rises after FDA accepts gastroparesis drug for review
• Vanda Pharmaceuticals GAAP EPS of $0.00 beats by $0.04, revenue of $38.82M misses by $5.68M
• Vanda Pharmaceuticals Q3 Earnings Preview
• Airbnb, Blackstone rise on joining S&P 500 index
• Vanda Pharmaceuticals GAAP EPS of $0.03, revenue of $46.06M
• Vanda gains on FDA orphan drug designation for nerve disorder candidate
• Vanda to consider options after appeals court ruling on Hetlioz generics
• Vanda Pharmaceuticals reports Q1 results
• Vanda wins FOIA litigation against FDA regarding Hetlioz for jet lag
• Super Bowl ads boost sales of drugs, yet only handful of companies advertising this year
• Vanda Pharmaceuticals GAAP EPS of $0.12 beats by $0.04, revenue of $64.5M misses by $3.1M
• Vanda Pharmaceuticals Q4 Earnings Preview
• Federal appeals court lifts injunction barring generics of Vanda's Hetlioz
• Federal appeals court temporarily blocks generics of Vanda's Hetlioz by Teva, Apotex
• Vanda Pharmaceuticals plunges after loss in Hetlioz patent case (update)